Using a new platform, Jonathan Constance, PhD, researcher at Huntsman Cancer Institute, studies commonly prescribed medications in hopes of creating more effective treatments for pediatric cancer patients.
Researchers found tumors release a protein that triggers an immune attack on brain cells, which causes rapid cognitive decline. This discovery could lead to new treatments for this serious complication.
Huntsman Cancer Institute welcomes a distinguished leader celebrated for advocacy into a new, vital role. In her position, she will continue the important work of advancing cancer research and mentorship.
Huntsman Cancer Institute's groundbreaking $20 million land donation from a developer for a new campus in Utah County promises expanded world-class care, breathtaking views, and reduced travel burden for patients.
The Society of Huntsman Translational Scholars adds Umang Swami, MD, MS, and Matthew Covington, MD, to its cohort that advances cancer testing and treatments through financial support and collaboration.
Alana Welm, PhD, director of basic science, earned the 2023 AACR Outstanding Investigator Award for her groundbreaking contributions to breast cancer research which have led to transformative advancements in treatment.
Neeraj Agarwal, MD, FASCO, observed remarkable outcomes in a larger group of Talapro-2 participants with specific gene mutations, combining two cancer drugs to effectively treat advanced prostate cancer.